Efgartigimod Combined With Steroid Treatment for HAM/TSP: A Case Report [PDF]
Annals of Clinical and Translational NeurologyHTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive neurological disorder with limited treatment options. We report a 54‐year‐old female with decade‐long, progressive HAM/TSP, previously refractory to rituximab, who ...
Jiahui Zeng +5 more
doaj +2 more sources
Lived Experience of Human T-cell Leukemia Virus type-1 -Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Phenomenology Study [PDF]
Iranian Journal of Medical SciencesBackground: Human T-cell Leukemia Virus type-1 (HTLV-1) -associated myelopathy causes sufferers to experience changes in several aspects of their lives.
Malihe Davoudi +2 more
doaj +2 more sources
Urodynamic findings and vibegron effects on neurogenic lower urinary tract dysfunction caused by human T‐cell leukemia virus type I‐associated myelopathy/tropical spastic paraparesis [PDF]
IJU Case ReportsIntroduction Human T‐cell lymphotropic virus type 1 infection can cause HTLV‐1‐associated myelopathy/tropical spastic paraparesis, characterized by spastic paralysis of both lower limbs. More than 90% of HAM/TSP patients show lower urinary tract symptoms
Tomoyuki Kumekawa +9 more
doaj +2 more sources
The Barriers of Coping with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Content Analysis Study [PDF]
Journal of Evidence-Based Care, 2023 Background: HTLV-1-associated myelopathy is associated with constant stress, so it is very important to cope with this disease. To improve the coping of patients with this disease, it is necessary to deeply identify its barriers.Aim: The present study ...
Malihe Davoudi +2 more
doaj +1 more source
Magnetic resonance imaging for Human T-cell lymphotropic virus type 1 (HTLV1-) associated myelopathy/tropical spastic paraparesis patients: a systematic review [PDF]
Reviews in Clinical Medicine, 2015 Introduction: Human T-cell lymphotropic virus type 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis is a chronic progressive neurologic disease which might be associated by brain and spinal cord atrophy and lesions.
Fariba Zemorshidi +2 more
doaj +3 more sources
Research on motor neuron diseases konzo and neurolathyrism : trends from 1990 to 2010 [PDF]
, 2012 Konzo (caused by consumption of improperly processed cassava, Manihot esculenta) and neurolathyrism (caused by prolonged overconsumption of grass pea, Lathyrus sativus) are two distinct non-infectious upper motor neurone diseases with identical clinical ...
Diasolua Ngudi, Delphin +3 more
core +10 more sources
IJU Case Reports, 2021 Introduction Neurogenic overactive bladder is a main feature of human T‐cell leukemia virus type 1‐associated myelopathy/tropical spastic paraparesis. We successfully performed intravesical onabotulinumtoxinA therapy for refractory neurogenic overactive ...
Tomohiro Matsuo +4 more
doaj +1 more source
Tropical spastic paraparesis – anesthetic approach
Brazilian Journal of Anesthesiology, 2017 Introduction: HTLV-1 infection is endemic in Japan, Caribbean, Africa, and South America. It is transmitted from mother to child, sexual contact, blood transfusions, or sharing needles.
Margarida Rodrigues +2 more
doaj +3 more sources
Aquaporin-4 Antibodies Are Not Related to HTLV-1\ud Associated Myelopathy [PDF]
, 2012 Introduction: The seroprevalence of human T-cell leukemia virus type 1 (HTLV-1) is very high among Brazilians (,1:200).\ud HTLV-1 associated myelopathy or tropical spastic paraparesis (HAM/TSP) is the most common neurological complication of\ud HTLV-1 ...
Brandão, Carlos Otávio +12 more
core +8 more sources
Effect of pulsed methylprednisolone on pain, in patients with HTLV-1-associated myelopathy [PDF]
, 2016 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immune mediated myelopathy caused by the human T-lymphotropic virus type 1 (HTLV-1). The efficacy of treatments used for patients with HAM/TSP is uncertain.
Adonis, A +8 more
core +1 more source